PETALING JAYA: Malaysian Genomics Resource Centre Bhd
(MGRC), a genomics and biopharmaceutical specialist, has bagged a contract for a Covid-19 surveillance by the Institute for Medical Research (IMR), the biomedical research arm under the Ministry of Health (MoH).
In a statement yesterday, MGRC said the company was one of the private laboratories that IMR has engaged to outsource genome surveillance of SARS-CoV2.
No value of the contract was stated.
“We are pleased to support IMR and MoH in this important effort to monitor the evolution of the Covid-19 virus, its variants and sub-variants.
“With our expertise and knowledge in genomics and bioinformatics, we can help IMR track and trace the virus for any variants of concern that the government needs to be informed of as well as prepare for,” said MGRC executive director Datuk Alvin Nesakumar.
He said the company’s cell laboratory is the only privately-owned BioSafety Level 2 (BSL-2) facility in Malaysia with the current Good Manufacturing Practice (cGMP) certification.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
